###begin article-title 0
###xml 32 48 32 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 32 48 <span type="species:ncbi:562">Escherichia coli</span>
Substitutions at tyrosine 66 of Escherichia coli uracil DNA glycosylase lead to characterization of an efficient enzyme that is recalcitrant to product inhibition
###end article-title 0
###begin p 1
###xml 95 122 95 122 <email xmlns:xlink="http://www.w3.org/1999/xlink">varshney@mcbl.iisc.ernet.in</email>
To whom correspondence should be addressed. Tel: +91 80 293 2686; Fax: +91 80 360 2697; Email: varshney@mcbl.iisc.ernet.in
###end p 1
###begin p 2
###xml 347 363 347 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 737 738 737 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 738 741 738 741 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 744 745 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 745 746 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 347 363 <span type="species:ncbi:562">Escherichia coli</span>
Uracil DNA glycosylase (UDG), a ubiquitous and highly specific enzyme, commences the uracil excision repair pathway. Structural studies have shown that the tyrosine in a highly conserved GQDPY water-activating loop of UDGs blocks the entry of thymine or purines into the active site pocket. To further understand the role of this tyrosine (Y66 in Escherichia coli UDG), we have overproduced and characterized Y66F, Y66H, Y66L and Y66W mutants. The complexes of the wild-type, Y66F, Y66H and Y66L UDGs with uracil DNA glycosylase inhibitor (Ugi) (a proteinaceous substrate mimic) were stable to 8 M urea. However, some dissociation of the complex involving the Y66W UDG occurred at this concentration of urea. The catalytic efficiencies (Vmax / Km) of the Y66L and Y66F mutants were similar to those of the wild-type UDG. However, the Y66W and Y66H mutants were approximately7- and approximately173-fold compromised, respectively, in their activities. Interestingly, the Y66W mutation has resulted in an enzyme which is resistant to product inhibition. Preferential utilization of a substrate enabling a long range contact between the -5 phosphate (upstream to the scissile uracil) and the enzyme, and the results of modeling studies showing that the uracil-binding cavity of Y66W is wider than those of the wild type and other mutant UDGs, suggest a weaker interaction between uracil and the Y66W mutant. Furthermore, the fluorescence spectroscopy of UDGs and their complexes with Ugi, in the presence of uracil or its analog, 5-bromouracil, suggests compromised binding of uracil in the active site pocket of the Y66W mutant. Lack of inhibition of the Y66W UDG by apyrimidinic DNA (AP-DNA) is discussed to highlight a potential additional role of Y66 in shielding the toxic effects of AP-DNA, by lowering the rate of its release for subsequent recognition by an AP endonuclease.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c1">1</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c1">1</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c3">3</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c4">4</xref>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c5">5</xref>
###xml 981 982 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c5">5</xref>
###xml 983 984 983 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c6">6</xref>
###xml 1205 1206 1205 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1207 1208 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1296 1297 1296 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c7">7</xref>
###xml 1298 1299 1298 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c9">9</xref>
Damage to DNA is perilous to cells as it alters the genetic code or obstructs recognition by the proteins (1). In order to prevent such threats, cells possess a number of repair enzymes, which actively search for damage in DNA and correct it. The RNA base uracil arises in DNA either by erroneous incorporation by DNA polymerases or as a consequence of cytosine deamination by physiological or environmental factors (1-3). Uracil DNA glycosylase (UDG), a ubiquitous enzyme (4) recognizes uracils in DNA and pioneers the uracil the excision repair pathway by cleaving the N-glycosidic bond between the base and DNA backbone to generate uracil and apyrimidinic DNA (AP-DNA) as reaction products (5). UDGs are highly conserved not only in their primary structure but also in the overall architecture of the tertiary fold, and are extremely specific for uracil in DNA. Uracil analog 5-bromouracil in DNA is neither acted upon by UDGs nor does it, in its free form, inhibit the enzyme (5,6), suggesting that substitution of non-polar hydrogen at the uracil position 5 with electronegative and/or bulky atoms is unfavorable for binding into the active site pocket of UDGs. On the other hand, analogs such as 6-(p-n-octylanilino) uracil, 5-azauracil and 6-aminouracil are known to inhibit various UDGs (7-9).
###end p 4
###begin p 5
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 121 123 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c10">10</xref>
###xml 140 141 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 142 143 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 204 205 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c7">7</xref>
###xml 286 287 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 287 288 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 315 316 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c3">3</xref>
###xml 317 318 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c9">9</xref>
###xml 319 321 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c13">13</xref>
###xml 528 530 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c14">14</xref>
###xml 531 533 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c15">15</xref>
###xml 892 894 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c16">16</xref>
###xml 895 897 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c18">18</xref>
UDGs are subject to product inhibition. The AP-DNA acts as a competitive inhibitor with a Ki of approximately1.2 microM (10). Similarly, 6-(p-n-octylanilino) uracil is a competitive inhibitor of HSV UDG (7). In contrast, uracil is known to be a non-competitive inhibitor of UDGs with a Ki of approximately0.2-5 mM (3,9-13). By definition, the non-competitive mode of inhibition means that the inhibitor binds to both the free enzyme and the enzyme-substrate complex. Since free uracil binds into the active site pocket of UDGs (14,15), the apparent non-competitive nature of inhibition may suggest additional site(s) of its binding on the enzyme. Yet another category of inhibitor is a phage encoded protein, uracil DNA glycosylase inhibitor (Ugi), a substrate mimic, which establishes an intricate network of interactions at the active site face of the UDGs to form a highly stable complex (16-18).
###end p 5
###begin p 6
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c14">14</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c15">15</xref>
###xml 320 336 320 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 395 398 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 597 600 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 792 793 792 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f1">1</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c19">19</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c21">21</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c19">19</xref>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c22">22</xref>
###xml 320 336 <span type="species:ncbi:562">Escherichia coli</span>
###xml 414 419 <span type="species:ncbi:9606">human</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
###xml 1007 1012 <span type="species:ncbi:9606">human</span>
The co-crystal structures of UDG with uracil containing DNA as well as free uracil have shown that uracil binding in the active site pocket occurs by extensive shape and charge complementarity (14,15). Several hydrogen bonds are established from the conserved UDG residues such as histidine of the HPSPLS motif [H187 in Escherichia coli UDG (EcoUDG)] and asparagine of the GVLLLN motif (N123 in EcoUDG and N204 in human UDG) to positions 2, 3 and 4 of uracil. Specificity of these contacts avoids cytosine binding in the pocket. Furthermore, the side chain of tyrosine of the GQDPYH motif (Y66 in EcoUDG and Y147 in human UDG), which is in van der Waals' contact with the C5 position of the uracil, excludes thymine with a methyl group at this position, or the purines with bulky rings (Fig. 1) (19-21). The significance of these interactions in the active site pocket as specificity determinants was highlighted in a protein- engineering quest wherein designed mutations (N204D, Y147A, Y147C and Y147S) in human UDG conferred detectable levels of altered substrate specificities of cytosine, and thymine DNA glycosylases, respectively, upon the mutant proteins (19). However, yet another pursuit in protein engineering is to design variants of the enzymes that are efficient in catalysis and that retain substrate specificity but become resistant to product inhibition (22).
###end p 6
###begin p 7
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
Recently, we proposed that the role of Y66 in EcoUDG is not restricted to merely preventing the entry of non-uracil residues into the active site pocket and that it also plays a role in catalysis of the glycosidic bond cleavage (23). To further our understanding of the significant role of Y66 in catalysis, product inhibition and interaction with Ugi, in this study, we have characterized additional mutants containing substitutions at the Y66 position.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Oligodeoxyribonucleotides
###end title 9
###begin p 10
###xml 354 359 <span type="species:ncbi:42554">tetra</span>
DNA oligomers were obtained from Ransom Hill Bioscience, USA, and Microsynth, Switzerland. The oligomers SSU9, d(ctcaagtgUaggcatgcaagagct), and SSU4, d(agcUcatagtttacctgaagaatat), are single-stranded 24mer and 25mer DNA containing dU at the 9th and the 4th positions, respectively. The substrate AU9, d(ctcaagtgUaggcatgcttttgcatgcctacacttga), is a 37mer tetra T-loop hairpin containing dU in the stem region, in the same sequence context as the SSU9.
###end p 10
###begin title 11
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
32P-labeling of oligodeoxyribonucleotides
###end title 11
###begin p 12
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 75 77 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 218 220 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c24">24</xref>
DNA oligomers (10 pmol) were 5' 32P-end-labeled using 10 microCi of [gamma-32P]ATP (6000 Ci/mmol) and T4 polynucleotide kinase in 10 microl reaction volumes and purified by chromatography on Sephadex G-50 minicolumns (24).
###end p 12
###begin title 13
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
Generation of the Y66 EcoUDG mutants and their over-expression constructs
###end title 13
###begin p 14
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c25">25</xref>
The NcoI-HindIII DNA fragment containing UDG open-reading frame (ORF) from pTrcEcoUDG(Y66F) (23) was subcloned into the respective sites of pET11d to generate pETEcoUDG(Y66F). To create remaining mutations, quick-change mutagenesis was performed on pTrcEcoUDG and pETEcoUDG, using Pfu DNA polymerase with the following DNA oligomer sets, d(ccaggatcctcatcacggacc) and d(ggtccgtgatgaggatcctgg), d(ccaggatcctttacacggacc) and d(ggtccgtgtaaaggatcctgg), and d(ccaggatccttggcacggacc) and d(ggtccg tgccaaggatcctgg), to generate Y66H, Y66L and Y66W mutations, respectively (23). The plasmid mini-preparations were sequenced to ascertain the mutations (25).
###end p 14
###begin title 15
Generation of UDG-Ugi bicistronic constructs
###end title 15
###begin p 16
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu</italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ccatgg</italic>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gaattc</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c25">25</xref>
The UDG ORFs from the pTrc99C constructs were amplified by PCR using Pfu DNA polymerase by the gene-specific forward, d(cggaattccatggctaacgaattaacc), and reverse, d(ggaattcctattactcactctctgcc), primers, digested with NcoI and EcoRI and cloned into the same sites of the pTrcUDG (L191G)-Ugi construct by replacing the UDG(L191G) ORF (26). To generate bicistronic constructs in the T7 RNA polymerase-based expression vector, NcoI-HindIII fragments harboring the complete bicistron from the pTrc99c constructs were subcloned into pET11d (25).
###end p 16
###begin title 17
Expression and purification of UDG and the UDG-Ugi complexes
###end title 17
###begin p 18
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c25">25</xref>
###xml 217 218 214 215 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 326 328 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
###xml 329 331 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c28">28</xref>
###xml 62 73 <span type="species:ncbi:511693">E.coli BL21</span>
###xml 75 78 <span type="species:ncbi:511693">DE3</span>
The pET11d-derived expression constructs were introduced into E.coli BL21 (DE3) and the transformants inoculated into 1 l of 2YT medium (25). At mid-log phase, the cells were induced with 0.5 mM isopropyl-1-thio-beta-d-galactopyranoside for 3-4 h. Cells were harvested; UDG and UDG-Ugi complexes were purified and quantified (26-28).
###end p 18
###begin title 19
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Analysis of the in vivo formed UDG-Ugi complexes
###end title 19
###begin p 20
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 261 262 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 310 311 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 437 439 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
###xml 72 78 <span type="species:ncbi:562">E.coli</span>
###xml 87 90 <span type="species:ncbi:511693">DE3</span>
The UDG-Ugi complexes from pET11d constructs were expressed as above in E.coli (BL-26, DE3) in 2 ml cultures, the cells were harvested by centrifugation, disrupted by sonication in 0.2 ml of TME buffer (25 mM Tris-HCl, pH 8.0, 2 mM beta-mercaptoethanol, 1 mM Na2EDTA) and clarified by centrifugation at 20 000 g for 10 min. The cell-free extracts were analyzed on 15% polyacrylamide (19:1 cross-linking) gels with or without 2-8 M urea (26).
###end p 20
###begin title 21
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 25 28 25 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
Determination of Km and Vmax
###end title 21
###begin p 22
###xml 92 94 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 213 214 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 401 409 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vacuo</italic>
###xml 679 680 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 697 698 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 736 737 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 744 745 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 748 750 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c29">29</xref>
###xml 774 775 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 775 776 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 781 782 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 782 785 754 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
Reactions (15 microl) containing varying amounts of SSU9 along with 20 000 c.p.m. of the 5' 32P-end-labeled counterpart and appropriate concentrations of UDG in the reaction buffer (50 mM Tris-HCl, pH 7.4, 1 mM Na2EDTA, 1 mM DTT and 25 microg/ml BSA) were incubated at 37degreesC for 10 min and stopped by adding 5 microl of 0.2 N NaOH. The reaction mixture was heated at 90degreesC for 30 min, dried in vacuo, taken up in 10 microl of loading dye, and half of the contents were electrophoresed on 15% polyacrylamide-8 M urea gels. The bands corresponding to the product and the leftover substrate were quantified using a BioImage Analyser (Fuji, FLA 2000). The percent product (P) and substrate (S) in each reaction were converted to [P] and [S] (29) and used to determine Km and Vmax from Hofstee plots of two independent experiments.
###end p 22
###begin title 23
Time course of uracil excision from AU9
###end title 23
###begin p 24
###xml 133 135 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
A reaction mixture (70 microl) was set up in UDG buffer containing 35 pmol of AU9 mixed with 20 000 c.p.m. of the same substrate (5' 32P-end-labeled), as tracer in each reaction. The reaction was started by adding 5 microl of an appropriate dilution of the UDG (2.5 pg for wild type, Y66F, Y66L or Y66W; 250 pg for Y66H) at 37degreesC. Aliquots (10 microl) were removed at 2, 4, 6, 8 and 10 min and the reactions were terminated and processed as above and analyzed on 15% polyacrylamide-8 M urea gel. The bands corresponding to substrate and product were quantified by a BioImage Analyser to calculate the percent product formed, which was in turn used to calculate pmoles of uracil released per microgram of UDG and plotted against time.
###end p 24
###begin title 25
Inhibition of UDG by uracil
###end title 25
###begin p 26
###xml 116 118 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
The reaction mixture (20 microl) was set up in 2x UDG buffer with 5 pmol of SSU9 along with 20 000 c.p.m. of its 5' 32P-end-labeled counterpart as tracer, in the absence or presence of different concentrations of uracil (2-12 mM). The reaction was started by addition of 5 microl of the same dilution of UDG to each tube of a set in the reaction buffer and incubated at 37degreesC for 10 min, terminated and processed as above and analyzed on 15% polyacrylamide-8 M urea gels. The bands corresponding to the product and the leftover substrate were quantified by using a BioImage Analyser.
###end p 26
###begin title 27
Inhibition of UDG by uracil and AP-DNA
###end title 27
###begin p 28
###xml 339 341 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 658 659 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 659 660 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
Reactions (5 microl) containing varying amounts of SSU9 (0, 1.25, 2.5 and 5 pmol) and appropriately diluted wild-type or mutant UDGs were incubated at 37degreesC for 30 min for complete excision of uracil for use as a source of AP-DNA. The reactions were added to another tube containing 5 pmol of SSU9 (along with 20 000 c.p.m. of the 5' 32P-end-labeled counterpart) in 2x UDG buffer in 15 microl volumes in the absence or presence of 5 mM uracil, and incubated further for 10 min at 37degreesC; the reactions were then terminated and analyzed on 15% polyacrylamide urea gels. The AP-DNA so prepared contains submicromolar levels of free uracil. Since, the Ki of uracil as inhibitor of UDG is approximately two to three orders of magnitude higher than that of AP-DNA, the presence of such small amounts of uracil is insignificant.
###end p 28
###begin title 29
Mixed substrate UDG assay
###end title 29
###begin p 30
###xml 131 133 127 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 148 150 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c24">24</xref>
###xml 617 618 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 622 623 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 626 627 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 643 644 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 649 650 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 785 786 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 789 790 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Reactions (10 microl) were set up in UDG buffer containing a total of 5 pmol (2.5 pmol each of SSU4 and SSU9) of quantitatively 5' 32P-end-labeled (24) substrates. The UDG reaction was started by adding 5 microl of the appropriate dilution of UDG at 37degreesC for 3 min and stopped by adding 5 microl of 0.2 N NaOH. The reactions were analyzed on 15% polyacrylamide-8 M urea gels, and the counts in the product and the leftover substrate bands corresponding to SSU4 and SSU9 were estimated using a BioImage Analyser. Values of percent product formed (uracil excision) from each of the substrates were calculated as [P / (S + P) x 100], where P and S represent counts in the product and leftover substrate bands corresponding to each of the substrates. The ratios of the total counts (S + P) of SSU9 versus SSU4 provide the relative amount of the substrates taken in the reaction, and the ratios of the percent product formed provide a measure of their relative utilization by each of the mutants.
###end p 30
###begin title 31
Changes in the intrinsic tryptophan fluorescence of UDG
###end title 31
###begin p 32
###xml 37 40 37 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">280</sub>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
UDGs or their complexes with Ugi (1 A280/ml) were incubated with urea (0, 2, 4, 6 or 8 M), uracil or 5-bromouracil (0-2 mM) for 2 h at room temperature and the fluorescence spectra were recorded using a spectrofluorimeter (Shimadzu RF-5301PC) (26). The excitation wavelength was 280 nm and the emission spectra were recorded between 300 and 400 nm.
###end p 32
###begin title 33
Structural modeling of the UDG mutants
###end title 33
###begin p 34
###xml 25 27 25 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ec</italic>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c30">30</xref>
###xml 755 756 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 790 791 753 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
Five models each of free EcoUDG and EcoUDG-uracil complexes were generated from crystal structures with Protein Data Bank code 1EUG and 2EUG, respectively (30). The models were generated by replacing Y66 with phenylalanine, leucine, histidine and tryptophan. Two models containing alternate conformations for the nearly symmetrical side chain of Y66H with a dihedral angle difference of 180degrees about the Cbeta-Cgamma bond were constructed. All the histidines were kept neutral and were protonated at Nepsilon. In the case of the Y66W mutant, of the two distinctly different conformers possible for the asymmetric side chain of tryptophan, only one was used. The other was ignored because of the larger exposed hydrophobic surface (by approximately34 A2) and burial of the polar Nepsilon1 atom. All the models, except that of Y66W, were sterically acceptable. However, in the Y66W mutant the larger side chain of tryptophan clashed with the main chain atoms of F77 and S78. This steric clash was removed by allowing residues 72-82 to move while keeping the rest of the structure fixed. This resulted in an acceptable model of Y66W with a slightly wider uracil pocket.
###end p 34
###begin title 35
RESULTS
###end title 35
###begin title 36
Purification of the UDG mutants
###end title 36
###begin p 37
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ung</italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c31">31</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c33">33</xref>
###xml 65 76 <span type="species:ncbi:511693">E.coli BL21</span>
###xml 78 81 <span type="species:ncbi:511693">DE3</span>
###xml 249 260 <span type="species:ncbi:511693">E.coli BL21</span>
###xml 262 265 <span type="species:ncbi:511693">DE3</span>
UDGs (wild type, Y66F, Y66H, Y66L and Y66W) were overproduced in E.coli BL21 (DE3) from T7 RNA polymerase-based high level expression constructs and purified to apparent homogeneity by using various column chromatography steps (26). Even though the E.coli BL21 (DE3) is wild type for ung, UDG preparations from such high level over-expression constructs are essentially free from the chromosomally encoded host UDG (31-33).
###end p 37
###begin title 38
Analysis of UDG-Ugi complexes
###end title 38
###begin p 39
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f2">2</xref>
To check for proper folding of the mutant UDGs, we used a substrate mimic, Ugi, to form complexes with them in vivo by using the bicistronic constructs. As shown in Figure 2, the mutant UDGs formed complexes with Ugi, which co-migrated with the wild-type UDG-Ugi complex (i, compare lane 1 with lanes 2-5) suggesting their proper folding. Furthermore, when analyzed for their stability in urea, the complexes of Ugi with the mutant UDGs (Y66F, Y66H and Y66L), like its complex with the wild-type UDG, remained unperturbed in 0-8 M urea (ii-v, lanes 2-4). However, some dissociation of theY66W UDG-Ugi complex occurred in 8 M urea (v, lane 5).
###end p 39
###begin title 40
Kinetics of uracil excision
###end title 40
###begin p 41
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg918tb1">1</xref>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 287 290 287 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 293 294 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 294 295 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 564 565 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f3">3</xref>
Kinetic parameters of uracil excision were determined to assess the effect of the mutations. Uracil excision from a single-stranded substrate, SSU9 (Table 1), showed that the wild-type and mutant UDGs have comparable Km but differ in their maximal velocity. The catalytic efficiencies (Vmax / Km) of uracil excision by the Y66L and Y66F mutants are similar to that of the wild-type UDG. However, the Y66W and Y66H mutants were compromised in their activities by approximately7- and approximately173-fold, respectively. Use of AU9 in a time course experiment (Fig. 3) suggested that, even for a double-stranded substrate, the Y66W and Y66H mutants were compromised to a similar extent as they were for SSU9. In addition, the Y66L and Y66F mutants excised uracil at a rate comparable to that of the wild-type UDG.
###end p 41
###begin title 42
Inhibition of UDGs with uracil and AP-DNA
###end title 42
###begin p 43
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f4">4</xref>
###xml 291 297 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 338 339 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c3">3</xref>
###xml 340 341 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c8">8</xref>
###xml 342 344 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c13">13</xref>
###xml 448 449 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f4">4</xref>
###xml 729 730 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f4">4</xref>
###xml 1007 1008 979 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f4">4</xref>
###xml 1362 1363 1306 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f4">4</xref>
###xml 291 297 <span type="species:ncbi:562">E.coli</span>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 326 331 <span type="species:ncbi:4565">wheat</span>
Uracil and AP-DNA are the products of the UDG reaction. Inclusion of uracil in the reactions (Fig. 4A) resulted in an inhibition of the wild-type, Y66L, Y66H and Y66F UDGs by approximately60%. These profiles of inhibition by uracil are identical to those obtained earlier with the UDGs from E.coli, human, HSV, mycoplasma and wheat germ (3,8-13). Interestingly, in these experiments, no inhibition of uracil excision by the Y66W UDG was seen (Fig. 4A). Also, upon inclusion of varying concentrations of AP-DNA (0.0625-0.25 microM) along with uracil (5 mM) in reactions, while the inhibition of the wild-type, Y66L, Y66H and Y66F UDGs increased to approximately80%, the Y66W UDG was still completely resistant to inhibition (Fig. 4B). Since the AP-DNA that we used in these reactions was prepared from the uracil containing DNA (Materials and Methods), to ensure that the preparation served as an inhibitor of UDGs, we carried out UDG assays in the absence of any externally added uracil. As shown in Figure 4C, at 0.25 microM concentration, the AP-DNA preparation inhibited the wild-type UDG by approximately50%. Interestingly, the Y66W mutant UDG was not inhibited at all. The other UDG mutants (Y66F, Y66H and Y66L) were inhibited to varying degrees. The Y66F protein was inhibited to a small extent by approximately20%. Even in the experiment shown in Figure 4B, upon addition of the AP-DNA in the reaction, this mutant showed the least increment in inhibition (over and above uracil inhibition). More importantly, these experiments identified the Y66W mutant as a UDG, which showed complete resistance to inhibition by both the products.
###end p 43
###begin title 44
Y66W UDG shows differential utilization of SSU9 over SSU4
###end title 44
###begin p 45
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c34">34</xref>
###xml 259 267 259 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 815 816 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f5">5</xref>
###xml 936 937 936 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f5">5</xref>
We have shown earlier that, with the addition of the -1, +1 and +2 phosphates (with respect to the scissile uracil), UDGs make an additional contact at the -5 phosphate (23,34). While this contact is not crucial for substrate utilization by the wild-type UDG in vitro, it is important for the activity of the mutant UDGs that are impaired in establishing a full complement of interactions with uracil in the active site pocket. The resistance of the Y66W UDG to uracil inhibition suggested its weak binding in the active site pocket. Hence, we checked for relative utilization of SSU9 and SSU4 by mutant UDGs in a mixed substrate (SSU9 and SSU4) assay. SSU9 contains the -5 phosphate, whereas the SSU4 lacks this phosphate even after 5' end phosphorylation (Materials and Methods). The quantification of data (Fig. 5) shows that, while the wild-type, Y66F, Y66H and Y66L UDGs use the substrates with similar relative efficiencies (Fig. 5, ii-v), the Y66W UDG utilized SSU9 >4-fold better than the SSU4 (vi).
###end p 45
###begin title 46
Widening of the uracil pocket in Y66W
###end title 46
###begin p 47
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f1">1</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f1">1</xref>
###xml 528 534 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c35">35</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c36">36</xref>
###xml 528 534 <span type="species:ncbi:562">E.coli</span>
As mentioned in Materials and Methods, a sterically acceptable model of the Y66W could be constructed only when the 72-82 polypeptide segment was allowed to move away from the center of the uracil binding cavity, to accommodate the larger size of the tryptophan side chain (Fig. 1B). The movement widens the uracil binding pocket, loosening the contacts between uracil and F77 (Fig. 1C). An analogous situation is observed in the case of mycobacterial RecA which has a lower affinity for nucleotides than its close homolog from E.coli. Modeling and crystal structures indicate that this difference occurs due to a wider nucleotide binding site in the case of mycobacterial RecA (35). In the case of the UDG mutants, the looseness of the fit in Y66W is quite conspicuous. While the shape complementarity coefficient between UDG and uracil varies between 0.78 and 0.81 for the WT, Y66F, Y66L and Y66H, it is 0.73 in the case of Y66W. These coefficients were computed using the Lawrence and Colman method (36), where a value of 1 on a scale of 0-1 indicated ideal compatibility between surfaces.
###end p 47
###begin p 48
Taken together, the preferential utilization of SSU9 over SSU4 by the Y66W UDG, and the molecular modeling studies, support the view that the interaction of uracil in the active site pocket of the Y66W UDG is compromised. This, in turn, would explain the lack of inhibition of Y66W by uracil.
###end p 48
###begin title 49
Changes in the intrinsic tryptophan fluorescence of UDGs and UDG-Ugi complexes in the presence of urea
###end title 49
###begin p 50
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f6">6</xref>
To further our understanding of the Y66W UDG, we subjected this and the wild-type UDGs to urea-mediated unfolding and monitored the changes in the intrinsic tryptophan fluorescence. In such experiments, unfolding of UDGs results in fluorescence quenching as well as in a red shift of the fluorescence spectra (26). As shown in Figure 6, the changes in the spectral profiles of both the wild-type and Y66W UDGs are very much alike and they both show a red shift upon treatment with 4 M urea (i and ii).
###end p 50
###begin p 51
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c26">26</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f6">6</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f6">6</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f2">2</xref>
Furthermore, as shown before (26), complexation of the wild-type UDG with Ugi makes it impervious to treatment even with 8 M urea, and in the intrinsic tryptophan fluorescence spectra, no red shifts [characteristic of decomposition of the complex (26)] are seen (Fig. 6, iii). However, when the complex of the Y66W UDG and Ugi was treated with 8 M urea (Fig. 6, iv), consistent with its dissociation on 8 M urea-containing gels (Fig. 2, v), it showed a red shift in the spectra. The observation that the free UDGs (wild type and Y66W) are alike in their resistance/susceptibility to urea, but among their complexes with Ugi, the UDG(Y66W)-Ugi, is slightly more susceptible to urea, suggests that the Y66W protein suffers a subtle structural change in the DNA binding/active site pocket which establishes contacts with Ugi, a substrate mimic (see Discussion).
###end p 51
###begin title 52
Changes in the intrinsic tryptophan fluorescence of UDGs and/or the UDG-Ugi in the presence of uracil or 5-bromouracil
###end title 52
###begin p 53
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f7">7</xref>
Treatment of UDGs or their complexes with uracil or 5-bromouracil led to changes in the intrinsic tryptophan fluorescence with no shifts in the spectra. As shown in the spectral recordings in Figure 7A, treatment of the wild-type UDG with increasing concentrations of uracil resulted in a gradual increase in fluorescence quenching (i). In contrast, under the identical assay conditions, treatment of the Y66W UDG did not result in significant fluorescence quenching at the lower concentrations of uracil (0-0.6 mM, ii). These observations suggest poor binding of uracil to the Y66W UDG.
###end p 53
###begin p 54
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">x</sub>
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 143 146 138 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 181 182 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 182 183 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">x</sub>
###xml 200 201 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 201 202 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 250 251 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f7">7</xref>
###xml 827 828 822 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f7">7</xref>
To gain better insight into these effects, we compared the profiles of the relative ratios (Fx / Fo) of the fluorescence intensities (at lambdamax of 332 nm) of the uracil treated (Fx) and untreated (Fo) samples for both the UDGs. As shown in Figure 7B (i), treatment of the wild-type UDG with uracil resulted in a distinct biphasic profile of quenching. While a biphasic profile is discernible even for the Y66W UDG, the amplitude of the first phase in this profile is much decreased. Interestingly, a control experiment, where the complexes of the two UDGs with Ugi (wherein access of uracil to the active site pocket of UDGs is blocked by Ugi) were treated with uracil, revealed identical profiles for both the samples (ii). Thus, a more rapid dip in the profile of the wild-type UDG at lower concentrations of uracil (Fig. 7B, i) suggests its high affinity binding in the active site pocket of the wild-type UDG. In yet another approach, the wild-type and the Y66W UDGs were treated with 5-bromouracil, an analog of uracil possessing a substitution at C5 position unfavorable for interaction in the active site pocket. In this experiment also, the relative fluorescence quenching profiles of the two UDGs were alike (iii). Taken together, these experiments suggest that the binding of free uracil to the active site pocket of the Y66W UDG is weak.
###end p 54
###begin title 55
DISCUSSION
###end title 55
###begin p 56
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f1">1</xref>
###xml 218 226 218 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg918tb1">1</xref>
###xml 868 869 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg918tb1">1</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
An extreme specificity in detection and removal of uracil by UDGs is rendered by interaction of uracil with a number of residues in its active site pocket (Fig. 1A). Recent studies involving mutational analysis of the in vitro produced EcoUDG mutants at the Y66 position, suggested that in addition to its role in uracil base selectivity, the van der Waals' interaction that it establishes with the C5 position of the uracil also facilitates the catalysis (23). In order to understand the role of Y66 further, we have overproduced several proteins mutated at this position (Y66F, Y66L, Y66H and Y66W). As summarized in Table 1, the catalytic efficiencies of the Y66L and Y66F proteins were very similar to those of the wild-type UDG. The observation that the mutant UDGs containing substitution of tyrosine with phenylalanine or leucine, but not with histidine (Table 1), cysteine or serine (23), were as active as the wild-type protein, suggests that a hydrophobic residue at this position is crucial for efficient catalysis.
###end p 56
###begin p 57
###xml 61 78 61 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f2">2</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c37">37</xref>
###xml 845 848 845 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c17">17</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c18">18</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c37">37</xref>
###xml 1063 1064 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f2">2</xref>
###xml 1069 1070 1069 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f6">6</xref>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c14">14</xref>
###xml 1461 1463 1461 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c15">15</xref>
###xml 1996 1998 1996 1998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c38">38</xref>
###xml 2364 2365 2364 2365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f5">5</xref>
###xml 2383 2385 2383 2385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
###xml 2594 2595 2594 2595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f7">7</xref>
###xml 2713 2715 2713 2715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c39">39</xref>
###xml 3170 3172 3158 3160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c23">23</xref>
###xml 3601 3603 3589 3591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c39">39</xref>
###xml 61 78 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 1835 1840 <span type="species:ncbi:9606">human</span>
All the conserved UDGs form a highly stable complex with the Bacillus subtilis phage, PBS-1, or -2, encoded proteinaceous inhibitor (Ugi). EcoUDG forms a complex with Ugi, which is physiologically irreversible and has been a good model system to understand the mechanism of protein-protein interaction. The Y66 side chain of EcoUDG forms a water-mediated hydrogen bond with E20 of Ugi. As shown in Figure 2, like the complex of the wild-type proteins, the complexes of mutant UDGs (Y66L, Y66H and Y66F) with Ugi were also stable in 8 M urea. Thus, the identity of tyrosine at this position is unimportant in forming a tight complex with Ugi. An earlier report showed that a mutant of Ugi (E20A) formed a weaker and reversible complex with UDG (37). However, it should be noted that E20 of Ugi, makes two more hydrogen bonds with S88 and S189 of EcoUDG (17,18), and a single mutation at this position in Ugi (E20A) will be expected to have a more severe phenotype, as observed (37). The presence of diminishing band of the UDG (Y66W)-Ugi complex in 8 M urea (Figs 2 and 6) is more likely a consequence of a subtle structural perturbation in the active site/DNA binding pocket, which is commonly utilized by both the Ugi and the substrate for their interaction with UDGs. Several other lines of evidence support this conclusion. (i) Co-crystal structures of uracil and UDG have shown that at least one site of uracil binding to UDGs is the active site pocket (14,15). Thus, unlike the uracil inhibition of the wild-type, Y66L, Y66F and Y66H UDGs, lack of uracil inhibition of the Y66W UDG indicates that uracil binding in its active site pocket is compromised. In fact, the modeled structures show that the active site pocket of the Y66W mutant is larger than those of the wild-type and the other mutant UDGs. (ii) In the co-crystals of human UDG with DNA, the equivalent of H67 (H148) in the neighbor of the equivalent of Y66 (Y147) forms hydrogen bonds with the uridine O4' and the -2 phosphate (38). Since the three-dimensional structural folds of the UDGs are highly conserved, the lack of inhibition of the Y66W UDG by AP-DNA would again suggest a structural perturbation in the uridine binding pocket of this mutant. (iii) The observation that, unlike the wild-type UDG and other mutants studied here, the Y66W UDG utilizes SSU9 preferentially over SSU4 (Fig. 5), also suggests (23) that the Y66W UDG is deficient in establishing a full complement of interactions in the uracil binding pocket. (iv) The changes in the relative intrinsic fluorescences of UDG in the presence of uracil (Fig. 7) support the view that the Y66W mutation has resulted in poor binding of uracil in its active site. Earlier studies (39) suggested that the rate of catalysis by UDG is limited by the slower rate of product release. Since the affinity of the products to the Y66W UDG is highly compromised (no inhibition by the products), it is quite likely that the actual efficiency of the glycosidic bond cleavage by the Y66W UDG is compromised to an extent larger than the apparent decrease of approximately7-fold in its overall rate. Importantly, and consistent with our earlier report (23), this observation supports the role of the Y66 residue in UDGs in assisting transition state substrate binding in the active site pocket and in decreasing the rate of product release. As the unprotected AP sites in DNA are mutagenic and toxic, Y66 of this repair enzyme (UDG) may perform an important function in shielding the AP site in DNA (by decreasing product release) until its recognition by a relevant AP endonuclease (39).
###end p 57
###begin p 58
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f7">7</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c7">7</xref>
###xml 398 399 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c3">3</xref>
###xml 400 401 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c8">8</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c13">13</xref>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f7">7</xref>
###xml 1171 1173 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c40">40</xref>
The fluorescence quenching studies (Fig. 7) allow us to draw further insights into the complex mechanism of UDG inhibition kinetics by uracil (7). The crystal structures have clearly revealed that by the virtue of uracil binding in the active site pocket, it should be a competitive inhibitor of UDGs. However, a number of biochemical studies have shown that uracil is a non-competitive inhibitor (3,8-13). The observed biphasic nature of the uracil binding profile to the wild-type UDG (Fig. 7B, i) suggests that in addition to binding to the active site pocket, uracil binds to UDGs at some other site(s) as well. The lack of Y66W UDG inhibition suggests that uracil binding to this site alone does not lead to a direct inhibition of enzyme activity. However, the binding of uracil to the second site may still facilitate its channeling into the active site pocket to result in a complex mode of inhibition, which is apparently non-competitive. Interestingly, from a physiological perspective, the additional binding site(s) on the enzyme may help in rapid localization of the substrate into the active site pocket of UDG and in conferring processivity to this enzyme (40).
###end p 58
###begin p 59
###xml 194 196 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c41">41</xref>
###xml 390 392 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg918c19">19</xref>
###xml 848 849 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg918f5">5</xref>
###xml 906 913 890 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 230 235 <span type="species:ncbi:9606">human</span>
Finally, while an N-terminal deletion construct (UNG1 DeltaN29) of human UDG1 (precursor of the mitochondrial UDG) is resistant to inhibition by AP-DNA, it is sensitive to inhibition by uracil (41). And, although the mutations in human UDG (Y147A and Y147C) have been described that are resistant to inhibition by uracil, these are >1000-fold compromised in their uracil excision activity (19). On the other hand, the Y66W UDG is only approximately7-fold compromised in its catalytic activity (compared with the wild-type counterpart). To our knowledge, the Y66W is the first characterized UDG mutant, which is an efficient enzyme and which shows no susceptibility to either of the reaction products. Furthermore, the observation that in the UDG assays, the only cleavage products that we detected corresponds to specific excision of uracils (Fig. 5), and the fact that the Y66W protein was hyperexpressed in vivo, clearly show that it retains high specificity towards uracils in DNA. The biochemical studies described here pave the way for determination of the structural basis of the fascinating properties of the Y66W UDG mutant.
###end p 59
###begin title 60
Figures and Tables
###end title 60
###begin p 61
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 387 388 387 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 160 166 <span type="species:ncbi:562">E.coli</span>
 (A) Uracil specificity pocket showing the interactions between the uracil residue, and the side chains of Y66, F77, N123 and H187 in the active site pocket of E.coli UDG (PDB code 1FLZ). (B) Stereo view of the superposition of uracil specificity pocket of the wild type (light gray) and the Y66W mutant (dark gray) subsequent to removal of short contacts in the Y66W mutant structure. (C) Accessible surface of the pocket (light gray) and the bound uracil (dark gray) illustrating the loosening of the fit in the Y66W mutant. H187 has been removed for clarity.
###end p 61
###begin p 62
 Stability of UDG-Ugi complexes. A Coomassie brilliant blue stained gel. Purified wild-type UDG-Ugi complex (lane 1) or the cell-free extracts (approximately15 microg) of the transformants (lanes 2-5) expressing UDG-Ugi complexes from the bicistronic constructs, as shown, were subjected to electrophoresis on 15% polyacrylamide gels containing different concentrations of urea. (i) Native gel (no urea); (ii) 2 M urea; (iii) 4 M urea; (iv) 6 M urea; and (v) 8 M urea.
###end p 62
###begin p 63
 Time course uracil excision by UDGs. Excision of uracil from a double-stranded DNA oligomer, AU9, by wild-type (triangles), Y66F (squares), Y66H (crosses), Y66L (diamonds) and Y66W (circles) UDGs. Reactions using appropriate dilutions (Materials and Methods) were carried out such that 30-50% of substrate was converted to product. The amount of product formed was calculated as pmoles of uracil released per microgram of UDG and plotted against time.
###end p 63
###begin p 64
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 698 699 698 699 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1398 1399 1394 1395 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
 Inhibition of UDGs by uracil and AP-DNA. (A) Inhibition by uracil: reactions were carried out using SSU9 with appropriately diluted UDGs, and the total product formed in the reactions with the wild-type, Y66F, Y66L, Y66H and Y66W UDGs was 2570, 2310, 3610, 2890 and 600 fmol, respectively, in the absence of externally added uracil, which was used as a reference for 100% activities. The products formed with the same dilutions of UDGs in the presence of uracil (2-12 mM) were calculated with respect to the reference values of the respective UDGs and plotted against uracil concentration (0-12 mM): wild-type (triangles), Y66F (squares), Y66H (crosses), Y66L (diamonds) and Y66W (circles) UDGs. (B) Inhibition by uracil and AP-DNA: UDG reactions were carried out in the presence of 5 mM uracil along with 0.062, 0.125 or 0.25 microM AP-DNA. The total amounts of product formed in the reactions with the wild-type, Y66F, Y66L, Y66H and Y66W UDGs were 1194, 999, 985, 1070 and 1870 fmol, respectively, in the absence of both the AP-DNA and uracil, which were used as reference for 100% activities. Activities in the presence of 5 mM uracil and the indicated amounts of AP-DNA were calculated with respect to these reference values for the respective UDGs and plotted against the AP-DNA concentration: wild-type (triangles), Y66F (squares), Y66H (crosses), Y66L (diamonds) and Y66W (circles) UDGs. (C) Same as (B) except that the experiment was carried in the absence of externally added uracil and in the presence of AP-DNA as inhibitor. The activities in the presence of AP-DNA were calculated with respect to the reference activities (100%) given in (B) and plotted as a histogram.
###end p 64
###begin p 65
###xml 381 382 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 386 387 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 390 391 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 407 408 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 413 414 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 549 550 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 553 554 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
 Mixed substrate UDG assay: equimolar amounts of oligomers SSU4 and SSU9 (2.5 pmol each) were either incubated in buffer alone (i) or with UDGs [wild type (ii), Y66F (iii), Y66H (iv), Y66L (v) and Y66W (vi)] for 3 min at 37degreesC and analyzed on 15% polyacrylamide-8 M urea gels. Values of percent product formed (uracil excision) from each of the substrates were calculated as [P / (S + P) x 100], where P and S represent counts in the product and leftover substrate bands corresponding to each of the substrates. The ratios of the total counts (S + P) of SSU9 versus SSU4 provide the relative amount of the substrates in the reactions, whereas the ratios of the percent product formed from SSU9 versus SSU4 provide a measure of their relative utilization by each of the mutants. The mean values +/- SD of three independent experiments are shown as histograms wherein the light gray bars and the dark gray bars represent the ratios of substrates taken in the reaction, and the ratios of the products formed, respectively. Representative autoradiograms have also been shown for each panel.
###end p 65
###begin p 66
###xml 148 151 148 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">280</sub>
 Spectrofluorimetric analysis of UDGs and its complexes with Ugi in the presence of urea: UDGs (wild type and Y66W) or their complexes with Ugi (1 A280/ml) were incubated with different concentrations of urea at room temperature for 2 h and the fluorescence spectra (300-400 nm) were recorded upon excitation at 280 nm. (i) Wild-type UDG; (ii) Y66W UDG; (iii) complex of the wild-type UDG with Ugi; and (iv) complex of the Y66W UDG with Ugi.
###end p 66
###begin p 67
###xml 32 33 32 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 63 66 63 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">280</sub>
###xml 262 263 262 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 312 313 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">x</sub>
###xml 316 317 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 457 458 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 514 517 509 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 559 560 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 560 561 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink">x</sub>
###xml 613 616 603 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
 Spectrofluorimetric analyses. (A) Wild-type and Y66W UDGs (1 A280/ml) were incubated with different concentration of uracil (i and ii, respectively) at room temperature for 2 h and the fluorescence spectra (300-400 nm) were recorded upon excitation at 280 nm. (B) (i) The mean values of relative fluorescence (Fx / Fo) from three independent experiments [a representative set is shown in (A)] were calculated and plotted against the ligand concentration [Fo represents the fluorescence intensity at 332 nm (lambdamax) of the untreated control sample whereas Fx represents fluorescence intensity at 332 nm (lambdamax) at a given concentration of uracil or 5-bromouracil]. (ii and iii) Same as in (i), except that the data from single sets of experiments wherein the UDG-Ugi complexes or UDGs were treated with uracil (ii) or 5-bromouracil (iii), respectively, are shown.
###end p 67
###begin title 68
Kinetic parameters of uracil excision from SSU9
###end title 68
###begin p 69
###xml 205 206 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 206 207 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 212 213 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 213 216 209 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
Reactions (15 microl) containing 0.5-30 pmol of SSU9 along with 1.25 (wild type, Y66L, Y66F), 12.5 (Y66W) or 125 pg (Y66H) of UDGs were carried out as described in Materials and Methods. Average values of Km and Vmax were calculated from two independent sets of experiments whose values were within 20% of the average.
###end p 69
###begin title 70
ACKNOWLEDGEMENTS
###end title 70
###begin p 71
We thank our laboratory colleagues for their suggestions. This work was supported in part by research grants from the Department of Biotechnology, Council of Scientific and Industrial Research (CSIR) and the Indian Council of Medical Research, New Delhi, India.
###end p 71
###begin title 72
REFERENCES
###end title 72

